UCSDccarta
45th Annual Summer Clinical Institute
June 2007 DATES TBA
David Deitch, PhD, is the Interim Director of the Center for Criminality and Addiction Research, Training and Application (CCARTA) at the currently Emeritus Professor of Clinical Psychiatry at the University of California, San Diego. Dr. Deitch has over 45 years of experience in the development of drug abuse treatment systems for adolescents and adults, nationally and internationally. In the non-profit public health sector, he was Co-Founder of Daytop Village, Inc., and also served as Senior Vice President and Chief Clinical Officer for Phoenix House’s Foundation. In the academic sector, he has had appointments at Temple University, the University of Chicago, University of California at San Francisco, as well as serving as Chief of Substance Abuse Services for the University of California, San Francisco. In the government sector, he has served as Coordinator of Curriculum and Faculty for the United Nations East Central European Drug Abuse Treatment Training Project; has consulted to a variety of Department of Corrections and Ministries of Justice and Health, in Latin America, SE Asia and Europe. Dr. Deitch served during the Johnson Administration as consultant to the Presidential Commission for the Study of Crime and Juvenile Delinquency, and the National Commission on Marijuana and Drug Abuse. During the Carter Administration, he chaired the White House Task Force on Prevention. He chaired the Curriculum Development Committee of the National Addiction Technology Transfer Centers, Technical Assistance Publication Series 21 — The Addiction Counseling Competencies: The Knowledge, Skills, and Attitudes of Professional Practice, used today as a guideline for corrections and community based substance abuse treatment organizations. He has further served as Regional Director of the Executive Committee of the Association for Medical Education and Research in Substance Abuse — Mentor Project (2000). He has numerous publications (and videos) in the field.
2016 UCSD Faculty
Frederick L. Altice, MD, MA, is Professor of Medicine at Yale University School of Medicine in New Haven, Connecticut. He is the Director of Clinical and Community Research of the Yale University AIDS Program for the School of Medicine, where he also directs the Community Health Care Van and the HIV in Prisons Program.
Dr. Altice's research interests are focused on the interface between infectious diseases and substance abuse. As a clinical epidemiologist, health services and intervention researcher, he has created novel programs for the treatment of HIV, HCV, and tuberculosis in vulnerable populations, including injection drug users and prison inmates. Specifically, he has been an international leader in research related to adherence to antiretroviral therapy, particularly among HIV+ drug users, has made considerable inroads into novel approaches using directly administered antiretroviral therapy and other structural interventions to facilitate adherence both nationally and internationally.
Dr. Altice has been at the forefront of integrating buprenorphine and methadone treatment into managing co-morbid conditions, including the management of HIV, HCV, TB and mental illness. He is the Principal Investigator on over 15 federally-funded grants, including numerous clinical investigations funded by the National Institutes on Health, the Substance Abuse and Mental Health Services Administration, Special Projects of National Significance for the Health Resources Services Agency and other federal agencies, Dr. Altice is currently leading studies that bridge the gap between the correctional and community setting, specifically on the use of directly observed antiretroviral therapy and opiate-substitution therapy. In addition to publishing his research in peer-reviewed journals, Dr. Altice has authored several significant books and book chapters. He lectures nationally and internationally on the subject of HIV, viral hepatitis, substance abuse and the management of medically complicated patients.
Current research includes methadone and buprenorphine as primary and secondary HIV prevention, directly administered antiretroviral therapy, peer-driven interventions, secondary prevention among drug users and prisoners and includes international projects in Malaysia, Ukraine and Iran.
Robert M. Anthenelli, M.D. is Professor and Executive Vice Chair in the Department of Psychiatry at the University of California, San Diego, School of Medicine where he directs the Pacific Treatment and Research Center. He previously served as the Associate Chief of Staff for Mental Health at the VA San Diego Healthcare System and Vice Chair for Veterans Affairs. He was formerly a Professor of Psychiatry, Psychology and Neuroscience at the University of Cincinnati, College of Medicine where he founded and directed the Center for Treatment, Research & Education in Addictive Disorders and the Addiction Sciences Division.
Dr. Anthenelli earned his baccalaureate degree from The Johns Hopkins University in Baltimore, Maryland, USA and his MD degree from The Johns Hopkins University School of Medicine. After graduating medical school, he completed his internship in internal medicine at Mercy Hospital in Baltimore. Dr. Anthenelli did residency training in psychiatry at the University of California, San Diego, School of Medicine. Additional post-doctoral training included a 2-year fellowship in addiction psychiatry research that was funded by the Department of Veterans Affairs.
The overarching theme of Dr. Anthenelli’s research is to develop improved treatments for tobacco and alcohol dependence by better understanding the neurobiology of these disorders. His lab group is also interested in the genetic influences on these disorders, the relationship between stress and relapse to addiction, and sex differences in stress and treatment responsivity. Funding for his research is provided by the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, the Department of Veterans Affairs, and various industry sponsors.
Jim Carter, Ph.D., is a licensed clinical and consulting psychologist. He formerly served as Associate Director of Addiction Treatment Services at Johns Hopkins School of Medicine, where he provided clinical services and oversight for patients on methadone and levo-α-acetylmethadol (LAAM) maintenance. Additionally, he co-authored CBT treatment manuals used in clinical trials research, and published peer reviewed articles focused on combining psychosocial and pharmacological treatments for patients with severe opioid use disorders. Currently, he maintains a private practice and serves as an expert consultant for organizations. Dr. Carter is a member of Motivational Interviewing Network of Trainers (MINT) and a diplomate in the Academy of Cognitive Therapy (ACT).
Igor Koutsenok, MD, MS is an addiction psychiatrist. He graduated as a medical doctor in 1982 at the National Medical University in Kiev, (Ukraine). In February 2014 he was appointed as Director of Prevention, Treatment, and Rehabilitation of the United Nations Office on Drugs and Crime, United Nations Office in Vienna, and served the UN for two terms until 2016, when he returned to the UCSD. Over the last 20 years Dr. Koutsenok was involved in the design and implementation of numerous training programs for addiction counselors, mental health practitioners, social workers and criminal justice professionals in California and multiple states of the United States. Dr. Koutsenok served as a trainer for the National Drug Court Institute in the USA, providing training and education for judges and members of the judicial system. Dr. Koutsenok is also a member of the International Motivational Interviewing Network of Trainers (MINT). For many years Dr. Koutsenok teaches general and addiction psychiatry to medical students, psychiatry residents, psychology trainees, social workers, criminal justice professionals, and policy makers around the world. He has authored and co-authored over 50 scientific publications and 5 book chapters.
Scott McClure, Ph.D., is self-employed as an independent consultant and trainer of evidenced based mental health, addiction, and criminal offender interventions. He is the Project Director and Creator of the California Department of Corrections and Rehabilitation’s Transformative Correctional Communication training initiative for the Office of Correctional Education and is a long time trainer for the National Institute of Corrections Offender Employment Retention Specialist initiative. Prior to this he was employed as a Prison Psychologist for the California Department of Corrections and Rehabilitation at the Substance Abuse Treatment Facility & Mule Creek State Prison respectively; and was the Principal Learning Skills Counselor at the University of California San Diego Center for Criminality & Addiction Research, Training, & Application. Dr. McClure’s specialties include motivational interviewing, cognitive behavioral interventions, adult education, trauma informed services, addiction, criminal justice rehabilitation, and multicultural competency.
Caroline Ridout Stewart, LCSW, was an intern at UCSD Outpatient Psychiatric Services in 1983. She is comfortable calling herself an “old timer” and has a deep and informed appreciation and understanding of the complex issues involved when one suffers from a psychiatric illness. Caroline is an expert in the treatment of anxiety disorders with particular interest in persons who suffer from panic and depersonalization. She ran the Panic Disorder Program here at Psychiatric Associates in the early 90s and now runs the CBT Group program for anxiety disorders with both an introductory and advanced group. Caroline also enjoys integrating mindfulness practices into all of her anxiety treatment. Caroline is the past--president of the Board of A New PATH (Parents for Addiction Treatment and Healing) and enjoys working both with persons who suffer from addictive illness and with their families. Caroline also sits on the board of the California Public Protection and Physician Health, Inc. This board works to promote confidential psychiatric treatment for physicians suffering from both addictive and psychiatric illness. Caroline was invited by Jim Hay, MD, past-President of the California Medical Society, to sit on this board because of her clinically-informed understanding of the need for a more harm-reductionist view of the treatment of co-occurring disorders. Caroline has been recognized as the San Diego recipient of the San Diego Business Journal’s 2010 Women Who Mean Business award. In July of this past year, she traveled to Washington, DC when A New PATH received the Joel Hernandez award sponsored by Faces and Voices of Recovery in recognition of PATH’s unrelenting advocacy for persons with addictive illness. Caroline is an adopted mother, essayist and artist.
Geoff Twitchell, PhD, is a Licensed Clinical Psychologist with 15 years of experience as a mental health clinician and educator. Dr. Twitchell has expertise in the areas of addiction, treatment with older adults, and chronic disease self-management. He graduated from Michigan State University, completed a predoctoral internship at the VA Greater Los Angeles HealthCare System, and then went on to complete a postdoctoral fellowship at theUniversity of California Los Angeles Neuropsychiatric Institute. Presently, Dr. Twitchell is the Supervising Psychologist for the Senior Intensive Outpatient Program at Sharp Healthcare's Grossmont Hospital in San Diego. Dr. Twitchell is a core faculty member of the APA-accredited Sharp psychology internship. Dr. Twitchell is also a Field Instructor for the San Diego State University School of Social Work.
Barth Wilsey, MD, is a researcher with the UCSD Center for Medicinal Cannabis Research studying the efficacy of cannabis for the treatment of neuropathic lower back pain. Prior to coming to UCSD, was a Joint Appointee at the UC Davis Medical Center and the Northern California Health Care System. He practiced Pain Medicine and performed clinical research at these affiliated institutions for 15 years. He had a strong interest in research ethics and chaired the institutional review boards at different times at both facilities. His research interests have centered on analgesic medications with publications involving prescription opioid abuse and medical marijuana. In addition, he has been interested in the interface between clinical practice and information technology and has worked on computer-assisted survey instruments.